Search

Your search keyword '"Eitner, Frank"' showing total 439 results

Search Constraints

Start Over You searched for: Author "Eitner, Frank" Remove constraint Author: "Eitner, Frank"
439 results on '"Eitner, Frank"'

Search Results

1. Author Correction: Genetic regulation of serum IgA levels and susceptibility to common immune, infectious, kidney, and cardio-metabolic traits

4. Genetic regulation of serum IgA levels and susceptibility to common immune, infectious, kidney, and cardio-metabolic traits

6. After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy

9. The sGC Activator Runcaciguat Has Kidney Protective Effects and Prevents a Decline of Kidney Function in ZSF1 Rats

10. International Society of Nephrology first consensus guidance for preclinical animal studies in translational nephrology

11. BAY-7081: A Potent, Selective, and Orally Bioavailable Cyanopyridone-Based PDE9A Inhibitor

12. International Society of Nephrology first consensus guidance for preclinical animal studies in translational nephrology

16. Sirolimus in renal transplant recipients with malignancies in Germany

19. Genetic regulation of serum IgA levels and susceptibility to common immune, infectious, kidney, and cardio-metabolic traits

24. Novel soluble guanylyl cyclase activators increase glomerular cGMP, induce vasodilation and improve blood flow in the murine kidney

25. Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: the German Chronic Kidney Disease (GCKD) study

26. Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort

27. Novel soluble guanylyl cyclase activators increase glomerular cGMP, induce vasodilation and improve blood flow in the murine kidney.

28. Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY 1101042)

34. HYPERTENSION: EXPERIMENTAL

40. Determinants of Successful Use of Sirolimus in Renal Transplant Patients

41. After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy

45. Contributors

47. The German Chronic Kidney Disease (GCKD) study: design and methods

Catalog

Books, media, physical & digital resources